Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04334174
Title Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas (BRENTICON-T)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Kansas Medical Center
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST